Introduced

Passed Senate

Passed House

Became law

Adjourned sine die. The bill was pending when the session ended, so it did not pass.

Last action · January 9, 2025

To Banking & Insurance (S)

Introduced January 7, 2025

Senate

Adjourned Sine Die

2025 Regular Session

SB12

AN ACT relating to prescription drugs.

Amend KRS 304.17A-164 to define terms; establish cost-sharing requirements for prescription drugs; require rebates to be passed through; establish confidentiality requirements for the rebate information; create a new section of KRS 365.880 to 365.900 to provide that the actual amount of rebates received is a trade secret; provide that compliance with prescription drug cost-sharing and rebate requirements shall not be in violation of the Uniform Trade Secrets Act; amend KRS 304.17C-125, 304.38A-115, 18A.225, and 164.2871…

Drugs and Medicines Education, Higher Effective Dates, Delayed Insurance, Health Pharmacists State Agencies State Employees Actuarial Analysis Health Benefit Plan Mandate Local Mandate State Employee Health Plan Mandate

Read the full text Kentucky Legislature LegiScan

AI-generated. Always verify with primary sources

Plain-language summary

Beta

This bill sets rules for how health insurance plans in Kentucky handle prescription drug costs and rebates. It requires that savings from drug rebates be passed on to patients, and it sets limits on how much patients can be charged out-of-pocket for prescription drugs. These rules would apply to most health plans in Kentucky, including the state employee health plan and health plans offered through public universities, starting January 1, 2026. Who it may affect: state employees, public university employees and students with school-sponsored health coverage, and Kentuckians enrolled in health plans subject to state insurance regulation.

Open official bill text (PDF)·Report a problem with the summary